J Capellades

29PUBLICATIONS
266CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markersMolecular targetsSensory processes, perception and performanceCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jul 20, 2026
Regulatory delay and lost opportunity in IDH-mutant low-grade glioma.

|Jul 02, 2026
Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU).

|Dec 04, 2025
Glasdegib in combination with temozolomide and radiotherapy in adult patients with newly diagnosed glioblastoma: the phase Ib/II GEINO 1602 trial.

María Ángeles Vaz-Salgado, Sonia Del Barco, Juan Manuel Sepúlveda

|Jul 08, 2025
Towards fair decentralized benchmarking of healthcare AI algorithms with the Federated Tumor Segmentation (FeTS) challenge.

Maximilian Zenk, Ujjwal Baid, Sarthak Pati

|Feb 13, 2025
Multikinase Treatment of Glioblastoma: Evaluating the Rationale for Regorafenib.

Ana Maria Muñoz-Mármol, Bárbara Meléndez, Ainhoa Hernandez

|Mar 19, 2024
Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial.

Patrick Roth, Thierry Gorlia, Jaap C Reijneveld

Pageof 5

Frequent Collaborators

6 joint publications

Wolfgang Wick

5 joint publications

Michael Weller

5 joint publications

Martin van den Bent

4 joint publications

Marion Smits